Bio
Abby Gordon is a MSc candidate in the Johnson lab at the University of British Columbia, where she studies ion channel modulation as a potential strategy to prevent type 1 diabetes. Her research focuses on inhibiting Nav1.7 channels to protect beta cells from immune-mediated destruction. Before joining the Johnson lab, Abby earned an Honours Bachelor’s degree in Life Sciences from Queen’s University.